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Fecal Microbiota Transplantation Is
Associated With Reduced Morbidity
and Mortality in Porcine Circovirus
Associated Disease
Megan C. Niederwerder1* , Laura A. Constance1, Raymond R. R. Rowland1,
Waseem Abbas2, Samodha C. Fernando2, Megan L. Potter3, Maureen A. Sheahan1,
Thomas E. Burkey2, Richard A. Hesse1,4 and Ada G. Cino-Ozuna1,4
1 Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS,
United States, 2 Department of Animal Science, University of Nebraska–Lincoln, Lincoln, NE, United States, 3 Abilene Animal
Hospital, PA, Abilene, KS, United States, 4 Kansas State Veterinary Diagnostic Laboratory, Kansas State University,
Manhattan, KS, United States
Porcine circovirus associated disease (PCVAD) is a term used to describe the multi-
factorial disease syndromes caused by porcine circovirus type 2 (PCV-2), which can be
reproduced in an experimental setting through the co-infection of pigs with PCV-2 and
porcine reproductive and respiratory syndrome virus (PRRSV). The resulting PCVAD-
affected pigs represent a subpopulation within the co-infected group. In co-infection
studies, the presence of increased microbiome diversity is linked to a reduction in clinical
signs. In this study, fecal microbiota transplantation (FMT) was investigated as a means
to prevent PCVAD in pigs co-infected with PRRSV and PCV-2d. The sources of the
FMT material were high-parity sows with a documented history of high health status
and robust litter characteristics. The analysis of the donated FMT material showed the
absence of common pathogens along with the presence of diverse microbial phyla
and families. One group of pigs (n = 10) was administered the FMT while a control
group (n = 10) was administered a sterile mock-transplant. Over the 42-day post-
infection period, the FMT group showed fewer PCVAD-affected pigs, as evidenced by a
significant reduction in morbidity and mortality in transplanted pigs, along with increased
antibody levels. Overall, this study provides evidence that FMT decreases the severity of
clinical signs following co-infection with PRRSV and PCV-2 by reducing the prevalence
of PCVAD.
Keywords: microbiome, swine, porcine reproductive and respiratory syndrome virus, porcine circovirus type 2,
fecal microbiota transplantation, porcine circovirus associated disease
INTRODUCTION
Fecal microbiota transplantation (FMT) is the process by which fecal microorganisms are donated
by a healthy individual and subsequently transplanted into a diseased individual. The actual process
of fecal transplantation has been described for centuries, being reported as early as the 4th century
in China for the treatment of diarrhea in humans (Zhang et al., 2012) and in the 17th century in
Italy as transfaunation for the treatment of diseases in ruminants (Borody et al., 2004). The recent
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surge in FMT usage and application is evidenced by a search
in PubMed, where publication results for either “FMT” or
“fecal microbiota transplant” comprise approximately 1,200
publications, with almost all being published within the last
decade (National Center for Biotechnology Information [NCBI],
2017). For several human disease states, FMT has been shown
to improve treatment outcome or resolve complex disease
conditions. Although recurrent Clostridium difficile infections are
by far the most frequent use for the application of FMT, other
FMT-treatable digestive diseases include inflammatory bowel
disease, ulcerative colitis, and metabolic syndrome (Borody and
Campbell, 2011; Vrieze et al., 2012; Weingarden and Vaughn,
2017). The mechanism by which FMT is effective for the
treatment of digestive diseases is likely associated with the
restoration of normal flora. FMT is also associated with the
improvement of non-digestive diseases, such as neurologic and
respiratory disorders. For these conditions, the mechanism for
the beneficial effect is likely more complex. For example, FMT
restored the production of cytokines, including TNF-α and IL-
10, in antibiotic-treated mice after respiratory infection with
Streptococcus pneumoniae (Schuijt et al., 2016).
A different and less-explored role for FMT is in the prevention
of disease. Traditionally, antibiotics and other growth promoters
have been used in food animal production as prophylactics.
Part of the benefit is likely derived from the maintenance of
a microbiome that optimizes growth, either through individual
species and/or metabolites, along with the prevention of
common bacterial infections. As beneficial microbial populations
are further characterized for their role in both growth and
immunity, FMT or other microbiome therapeutics may provide
an alternative to antibiotics and growth promoters in food animal
production.
Porcine reproductive and respiratory syndrome virus
(PRRSV) is the most costly disease of swine worldwide, with
estimated annual losses to the US industry at $664 million,
primarily due to respiratory disease and reduced weight gain in
growing pigs (Holtkamp et al., 2013). Porcine circovirus type
2 (PCV-2) is also a significant and widely distributed pathogen
of swine. PCV-2 is a causative factor associated with a group of
disease syndromes termed porcine circovirus associated disease
or PCVAD, characterized by muscle wasting, respiratory disease,
jaundice, or pallor, and reduced weight gain in growing pigs
(Segales, 2012). Models for PCVAD include co-infection with
PRRSV and PCV-2, both of which cause systemic infections
primarily targeting pulmonary and lymphoid tissues (Trible
et al., 2012; Niederwerder et al., 2015, 2016).
Previous work utilizing a PRRSV/PCV-2 co-infection model
has shown a consistent association between increased fecal
microbiota diversity and improved outcome in nursery pigs
(Niederwerder et al., 2016; Ober et al., 2017). Specifically,
both pre- and post-infection fecal microbiome diversity was
associated with several improved outcomes after co-infection,
including reduced clinical disease severity, reduced virus
replication, decreased lung lesions, and improved weight gain.
Increased microbiome diversity, as measured by a pan-microbial
microarray, was correlated with a reduction in PCVAD clinical
signs as well as improved growth in subclinically affected pigs.
The hypothesis tested in the current study was that
prophylactic administration of FMT to 3-week-old weaned
barrows prior to co-infection with PRRSV and PCV-2 would
reduce clinical signs and pathology associated with PCVAD.
The sources of the FMT material were high-parity sows with
life-long histories of high-health status and efficient production
characteristics, such as the absence of frequent antimicrobial
treatment, low pre-weaning mortality rates, large healthy litters,
and a lack of clinical disease. The results showed that FMT
reduces the number of pigs affected by PCVAD, including
a reduction in virus load and increased viral antigen-specific
antibodies. Therefore, FMT provides a potential therapeutic for
the prevention of disease.
MATERIALS AND METHODS
Animals and Housing
The use of animals and viruses in research was performed in
accordance with the Federation of Animal Science Societies
(FASS) Guide for the Care and Use of Agricultural Animals
in Research and Teaching, the USDA Animal Welfare Act and
Animal Welfare Regulations, and approved by the Kansas State
University Institutional Animal Care and Use Committees and
Institutional Biosafety Committees. Ten pairs of barrow siblings
(n = 20; 24 days of age upon arrival) were obtained at weaning
from a single high health commercial source negative for PRRSV,
Mycoplasma hyopneumoniae, and porcine epidemic diarrhea
virus (PEDV). Sibling pairs were from 10 different sows and
the piglets were not vaccinated for PCV-2. No prophylactic or
therapeutic antibiotics were administered at weaning or within
1 week of arriving at Kansas State. All pigs were housed in two
identical environmentally controlled rooms at the Kansas State
University Large Animal Research Center and maintained under
biosafety level 2 (BSL-2) conditions. Each sibling pair was divided
into either the control or fecal microbiota transplantation (FMT)
group; the two groups were balanced according to arrival weight.
Pigs were housed in groups of 10 in a 9.1 square meter pen with
raised slatted flooring. All pigs were given approximately 24 h
to acclimate to their new environment prior to FMT or mock-
transplant treatment. Pigs were given access to food and water
ad libitum.
Viruses
The PRRS virus (isolate KS62; GenBank accession no.
KM035798) used to prepare the inoculum for this study
originated from the lymph node of a pig with PCVAD due to
co-infection with PRRSV and PCV-2 (Trible et al., 2012). PRRSV
was isolated by propagation on MARC-145 cells and titrated as
previously described (Niederwerder et al., 2015).
The PCV-2d virus was a field-derived isolate. Serum
containing the field isolate was heat-treated to remove heat-
labile pathogens and was subsequently used to infect cesarean-
derived, colostrum-deprived (CD/CD) pigs. Lung, spleen, and
liver samples were collected from the CD/CD pigs at 21 days post-
infection (dpi) and tested by qPCR for PCV-2d. Quantification
cycle (Cq) values of the tissues used to create the inoculum for the
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current study were 14.9, 14.2, and 14.2 for liver, lung, and spleen,
respectively, from a single CD/CD pig. A 10% tissue homogenate
was created from the described tissues in Eagle’s minimum
essential medium (EMEM; Sigma-Aldrich) supplemented with
50 µg/ml gentamicin. Following centrifugation at 100 × g
for 15 min at 4◦C, the supernatant was heat-treated at 55◦C
for 45 min to inactivate heat-labile pathogens. Analysis of the
supernatant using the Lawrence Livermore Microbial Detection
Array (LLMDA) confirmed the inoculum was negative for other
common pathogens, such as porcine parvovirus, PRRSV, swine
influenza virus, and Mycoplasma hyopneumoniae, but remained
positive for porcine endogenous retroviruses (data not shown),
which are ubiquitous in swine. PCV-2d infectivity was titrated
on swine testicle (ST) cells. Briefly, serial 10-fold dilutions of
PCV-2d challenge stock were added in quadruplicate onto rapidly
dividing ST cells in a 96-well tissue culture plate (BD Falcon).
Dilutions were prepared in Eagle’s minimal essential medium
(EMEM; Sigma-Aldrich) supplemented with 7% fetal bovine
serum (FBS; Sigma-Aldrich) and 50 µg/ml gentamicin (Lonza).
Following a 3-day incubation at 37◦C in 5% CO2, cells were fixed
and permeabilized with 80% acetone. Cells were then stained with
a polyclonal anti-PCV-2b primary antibody and a fluorescein
(FITC) AffiniPure Goat Anti-Swine IgG secondary antibody
(Jackson ImmunoResearch Laboratories, Inc.). Infected cells were
visualized using an inverted fluorescent microscope and the 50%
tissue culture infective dose (TCID50/ml) was calculated using the
method of Spearman and Karber (Finney, 1964).
To prepare the inocula for pigs, the stock viruses were mixed
to yield a 2-ml dose consisting of 104 TCID50 PCV-2d and 105
TCID50 PRRSV in MEM. The 2-ml dose was split, with 1 ml being
delivered intranasally and 1 ml being delivered intramuscularly.
Fecal Microbiota Transplant
Two sows from a commercial farrow-to-wean farm in Kansas
were selected as donors for the transplant material. This
herd was negative for PRRSV and had recently undergone a
M. hyopneumoniae elimination program. The two sows were
selected based on several characteristics, including older age
(average age 4.8 years), high parity (9 and 12 litters born prior
to donation), large litters with a high percentage of born alive
piglets (15.1 ± 2.0 total born; 95% born alive), low pre-weaning
mortality, no history of fetal mummification, and no antibiotic
treatment received within at least the last 15 months prior to
donation. Pre-weaning mortality in these two sows was primarily
attributed to crushing injuries. Lifetime number of weaned pigs
was 101 and 131 for each sow, respectively. For this study, feces
were collected during lactation and sows had not yet weaned their
respective litters at the time. Feces were initially screened and
confirmed as negative for gastrointestinal parasites using a fecal
float qualitative exam by the Kansas State Veterinary Diagnostic
Laboratory (KSVDL).
To prepare the FMT, fresh feces was collected naturally during
defecation or manually from the rectum of the two sows. Feces
were collected on a single time and day, mixed, and processed
within approximately 3 h after collection, during which the
fecal microbiota was concentrated and stored using a protocol
adapted from the human FMT literature (Hamilton et al., 2012).
Specifically, feces were weighed into 50 g aliquots and mixed in
a standard commercial blender (Oster, Sunbeam Products Inc.)
with 250 ml of sterile saline (0.9% sodium chloride irrigation USP,
Braun Medical) until homogenized. The fecal slurry was then
passed progressively through 2.0, 1.0, 0.5, and 0.25 mm stainless
steel sieves into a sieve receiver (FisherbrandTM). The filtered
liquid was collected, aliquoted into 50 ml tubes, and centrifuged
at 6,000 × g for 15 min. The supernatant was discarded and
each bacterial pellet was resuspended in approximately 20 ml
of sterile saline. All resuspensions were gently vortexed prior to
mixing the concentrated microbiota in a large beaker. Glycerol
(molecular biology reagent grade, MP BiomedicalsTM) was added
to create a 10% glycerol suspension and the transplant material
was stored at −80◦C until the day of transplantation. On the day
of transplantation, the FMT material was thawed for 2 h on ice
and kept cold prior to administration.
The FMT material was submitted to KSVDL for routine
bacterial culture, including aerobic culture, anaerobic culture,
and Salmonella enrichment. Species identification was attempted
for all bacteria cultured. The FMT material was also fully
characterized on the LLMDA.
Experimental Design and Sample
Collection
Approximately 24 h after arriving at Kansas State University,
pigs were administered a fecal microbiota transplant or a mock
transplant (CONTROL). Mock transplants were made of 10%
glycerol in sterile saline. Transplants or mock-transplants were
administered as 5 ml doses delivered once daily for seven
consecutive days prior to co-infection. To administer the FMT
or mock-transplant, 5 ml doses were delivered through flexible
dispensing tips (6.4 mm FlexojectTM Dispensing Tips, Innovet).
Solutions were delivered slowly on the tongue or in the cheek
pouch, allowing the pig to chew on the tip and naturally consume
the material over 30 s to 1 min.
At 32 days of age, all 20 pigs were infected with PRRSV
and PCV-2d. Body weights of individual pigs were collected
upon arrival (−8) and on −7, 0, 7, 14, 21, 24, 28, 32, 35,
and 42 dpi. Blood samples were collected from all pigs on −7,
0, 4, 7, 11, 14, 21, 28, 35, and 42 dpi. Fecal samples were
collected from all 20 pigs on −7 and 0 dpi. In addition to these
planned sample collection times, blood, feces, and weights were
collected on the day of death or euthanasia. Pigs were humanely
euthanized under the direction of the attending laboratory animal
veterinarian if (1) pigs had greater than or equal to 20% weight
loss, (2) pigs were moribund or nonresponsive to veterinary
treatment, or (3) pigs had severe dyspnea or clinical disease
that compromised animal welfare. At 42 dpi, all remaining pigs
were humanely euthanized in accordance with the American
Veterinary Medical Association Guidelines for the Euthanasia of
Animals and complete necropsies were performed.
Clinical and Pathologic Evaluation
All pigs were assessed daily for the presence of clinical signs
associated with PRRSV/PCV-2 co-infection, such as dyspnea,
tachypnea, ocular discharge or conjunctivitis, coughing or
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sneezing, nasal discharge, aural cyanosis, open mouth breathing,
decreased body condition, muscle wasting, rough hair coat,
lethargy, depression, joint effusion, lameness, diarrhea, and pallor
or jaundice. Pigs were visually examined by a veterinarian or
veterinary assistant on each day of the study period. Under the
direction of the attending veterinarian, appropriate treatments
were administered to pigs with moderate to severe clinical
disease. Examples of clinical presentations where treatment
was administered included (1) dyspnea and/or tachypnea, (2)
mucoid rhinorrhea, (3) conjunctivitis with swelling, (4) pallor
or jaundice with muscle wasting, and (5) lethargy or depression
with pyrexia. Clinically affected pigs were prescribed parenteral
antibiotics, such as ceftiofur hydrochloride or oxytetracycline.
Any pig with overt clinical disease and a rectal temperature
of ≥104◦F was administered parenteral flunixin meglumine,
a nonsteroidal anti-inflammatory drug. Other supportive care,
such as oral or subcutaneous fluids, was administered for
significantly dehydrated pigs under the direction of the
attending veterinarian. Pigs with evidence of conjunctivitis were
treated with triple antibiotic ophthalmic ointment (bacitracin–
neomycin–polymyxin, Vetropolycin, Dechra). Clinical signs and
treatments unrelated to PRRSV or PCVAD (e.g., lacerations,
dermatitis, congenital hernias, etc.) were documented and
monitored but were not included in the data analysis related to
clinical outcome. Treatment days were numerated for individual
pigs over time. Treatment days were counted as each day
a pig was prescribed a parenteral therapeutic. Mortality rate
was calculated from those pigs that died or were euthanized
prior to the 42-day termination of the study. Morbidity rate
was calculated as the number of pigs demonstrating clinical
signs deemed by the attending veterinarian to require veterinary
intervention and prescription of parenteral therapy.
At 42 dpi, all surviving pigs (n = 11) were humanely
euthanized with intravenous pentobarbital sodium. A board
certified veterinary pathologist, blinded to the source of the
pigs, performed complete necropsies and histopathology. First,
whole body weights were collected post-mortem. Second, lungs
and trachea were removed in toto immediately after euthanasia
and total lung weights were measured. The trachea was excised
immediately distal to the larynx. Lung weight to body weight ratio
was calculated as a measure of pulmonary pathology. Dorsal and
ventral aspects of the whole lung were photographed (Canon EOS
Rebel T6 DSLR) and digital images were evaluated after gross
necropsy using a photo scoring system. Gross anatomical photo
scores were reported as the percentage of whole lung affected
by pneumonia (ranging from 0 to 100%). Scores were combined
from five sections of the lung as previously described (Halbur
et al., 1995). The photos were evaluated by a board certified
veterinary pathologist who was blinded to the source of the lung
pictures.
Tissues collected for histopathology included lung (one
section from each lobe) and tracheobronchial lymph node.
Additional tissues were collected at the pathologist’s discretion
by evidence of gross lesions. Tissues were fixed in 10% neutral
buffered formalin for at least 7 days, routinely processed in
an automated tissue processor, embedded in paraffin, and
stained with hematoxylin and eosin (H&E stain). Microscopic
lung lesions were scored using a 0–4 system as previously
described (Niederwerder et al., 2015, 2016). Degree of lymphoid
depletion was scored using a 0–3 system as previously described
(Niederwerder et al., 2016).
PCV-2 Immunohistochemical Staining
Porcine circovirus type 2 antigen staining in paraffin-embedded
tissue thin sections was performed by personnel in the KSVDL.
Briefly, deparaffinized slide-mounted thin sections were first
treated with proteinase K (1.2 mg/ml diluted in Bond Enzyme
Diluent with 0.35% ProClin 950) for 10 min at room temperature
(Bond Enzyme Pretreatment Kit, Leica Biosystems). Rabbit anti-
PCV-2 antibody (Iowa State University) was diluted at 1:500 in
PowerVision IHC/ISH Super Blocking (Leica Biosystems) and
applied to the tissue section for 15 min at room temperature.
Bound antibody was detected by incubation with 25 µg/ml Poly-
AP anti-rabbit IgG (Leica Biosystems) in antibody diluent for
25 min at room temperature. The complex was visualized using
Fast Red chromogen (Bond Polymer Refine Red Detection Kit,
Leica Biosystems) and counterstained with hematoxylin.
Measurement of PRRSV and PCV-2
Viremia
Viral DNA and RNA was extracted simultaneously from 50 µl of
serum using Ambion’s MagMAX 96 Viral Isolation Kit (Applied
Biosystems) in accordance with the manufacturer’s instructions.
PRRS viral RNA was quantified using EZ-PRRSV MPX 4.0 Real
Time RT-PCR Target-Specific Reagents (Tetracore) according
to the manufacturer’s instructions. For consistency, each plate
contained Tetracore Quantification Standards and Control Sets
for use with EZ-PRRSV MPX 4.0 RT-PCR Reagents. All PCR
reactions were carried out on a CFX96 Touch Real-Time PCR
Detection System (Bio-Rad) in a 96-well format using the
recommended cycling parameters. The PCR assay results were
reported as log10 PRRSV RNA starting quantity (copy number)
per 25 µl reaction volume.
Porcine circovirus type 2d DNA was quantified using
SsoAdvanced Universal SYBR green supermix (Bio-Rad) as
previously described (Niederwerder et al., 2015, 2016). The PCR
assay results were reported as log10 PCV-2 DNA starting quantity
(copy number) per 20 µl reaction volume.
Microsphere Immunoassay for Detection
of PRRSV and PCV-2 Antibodies
Porcine reproductive and respiratory syndrome virus
nucleocapsid protein and PCV-2b capsid protein fragments
(43-233 and 160-233) were cloned into the pHUE expression
vector, as previously described (Trible et al., 2011). For protein
expression, bacteria were grown in Luria-Bertani (LB) broth plus
ampicillin (0.01 mg/ml) and incubated at 37◦C with shaking.
Once the OD600 reached 0.4–0.6, protein expression was induced
by adding 1 ml of 0.1 M isopropyl β-D-1-thiogalactopyranoside
(IPTG) to the culture and bacteria were harvested 4 h later.
Bacteria were pelleted by centrifugation at 4,000 × g for 10
min. Soluble proteins were purified using the USB PrepEase
Histidine-tagged Protein Purification Kit (Affymetrix) under
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non-denaturing conditions, according to the manufacturer’s
directions. Purity was assessed by SDS–PAGE and total protein
measured using the Bio-Rad Protein Assay.
Proteins were coupled to carboxylated Luminex MagPlex R©
polystyrene microspheres according to the manufacturer’s
directions. For the assay, approximately 2500 antigen-coated
beads, suspended in 50 µl PBS with 0.05% Tween-20 and 4%
goat serum (PBST-GS), were placed in each well of a 96-well
polystyrene round bottom plate (Costar). Sera were diluted 1:400
in PBST-GS and 50 µl was added to each well. The plate was
sealed and incubated for 30 min at room temperature with
gentle shaking. After the incubation, the plate was placed on
a magnet and beads were washed three times with 190 µl
of PBST-GS. For the detection of IgG, 50 µl of biotin-SP-
conjugated affinity purified goat anti-swine secondary antibody
(IgG, Jackson ImmunoResearch) was diluted to 2 µg/ml in
PBST-GS and 100 µl was added to each well. The plate was
incubated at room temperature for 30 min and washed three
times followed by the addition of 50µl of streptavidin-conjugated
phycoerythrin (2 µg/ml in PBST-GS; SAPE). After 30 min,
the plate was washed and microspheres resuspended in 100 µl
of PBST-GS. Microspheres were analyzed using a MAGPIX
instrument (Luminex) and Luminex R© xPONENT 4.2 software.
A minimum of 50 microspheres was used for the calculation of
mean fluorescence intensity (MFI). The sample to positive (S/P)
ratio was calculated as the MFI of sample minus MFI of negative
control divided by MFI of standard positive control minus MFI
of negative control.
Microarray Analysis of FMT and Fecal
Samples
The LLMDA was used to analyze microbiome composition
and diversity of the transplant material and fecal samples.
This array detects annotated sequences of microbes associated
with infection of vertebrates within GenBank R©, the National
Institute of Health genetic sequence database. The version 7
of the LLMDA in the 4plex 180K probe format was used
in this study. This version of the array targets 4,377 viruses,
5,457 bacteria, 327 archaea, 319 fungi, and 132 protozoa.
The LLMDA oligonucleotide probes vary between 50 and 65
nucleotides in length and have roughly equivalent affinities
for their complementary target DNA molecules (McLoughlin,
2011). Probes were designed to detect all sequenced microbial
families with a large number of probes per sequence (average
of 30 probes) to improve sensitivity in the evaluation of
microbial nucleic acids in a variety of samples. The high-
density oligo LLMDA microarray and statistical analysis method
have been extensively tested in numerous studies for viral
and bacterial detection in pure or complex environmental
and clinical samples (Gardner et al., 2010; Rosenstierne et al.,
2014; Jaing et al., 2015; Niederwerder et al., 2016; Ober et al.,
2017).
The PowerViralTM Environmental RNA/DNA Isolation Kit
(MO BIO, San Diego, CA, United States) was used to extract DNA
and RNA from the fecal samples. For each sample, approximately
250 mg of feces was added to 600µl of PV1/β-mercaptoethanol in
a glass beat tube included in the kit. Samples were homogenized
and lysed by vortexing tubes for 10 min at maximum speed.
Samples were further processed using the PowerViralTM Kit
protocol. All samples were eluted into 100 µl of RNase-free water.
The purified nucleic acids were quantified using the Thermo
ScientificTM NanodropTM spectrophotometer. For each sample,
10 µl of the extracted DNA and RNA was amplified using
the random amplification procedure as previously described
(Rosenstierne et al., 2014). The amplified cDNA and DNA was
purified with the Qiaquick PCR purification columns (Qiagen)
and quantified using the NanodropTM spectrophotometer.
Approximately 1 µg of amplified cDNA and DNA were
fluorescently labeled using a one-coloring labeling kit (Roche
NimbleGen, Madison, WI, United States). Briefly, the samples
were labeled using nick translation with Cy3-labeled random
nonamer primers (TriLink Biotechnologies, San Diego, CA,
United States) and Klenow DNA polymerase at 37◦C for 2 h.
The labeled DNA was precipitated in isopropanol, centrifuged for
10 min, and the pellet was washed and dried. The pellet was then
reconstituted in 50 µl of RNase-free water and quantified using
the Nanodrop spectrophotometer.
The Agilent Technologies Oligo aCGH/ChIP-on-Chip
Hybridization kit (Santa Clara, CA, United States) was used
to hybridize samples to the arrays. For each sample, 10 µg
of fluorescently labeled DNA was mixed with blocking agent,
hybridization buffer and nuclease-free water. The samples
were then denatured at 95◦C for 3 min, and incubated at 65◦C
for 3 min. Each sample was then immediately loaded onto
the array and hybridized for approximately 40 h at 65◦C in
a microarray rotator oven (Agilent Technologies Inc., Santa
Clara, CA, United States) set to a speed of 20. Microarrays were
then washed using the standard manufacturer’s protocol with
Oligo aCGH/ChIP-on-chip Wash Buffer 1 for 5 min at room
temperature and Oligo aCGH/ChIP-on-chip Wash Buffer 2
for 1 min at 37◦C (Agilent Technologies Inc., Santa Clara, CA,
United States). Using the SureScan Microarray Scanner (Agilent
Technologies Inc., Santa Clara, CA, United States), all arrays
were scanned to a resolution of 3 µm.
Microarray data were generated from the microbe sequences
using the CLiMax method developed at Lawrence Livermore
National Laboratory (Gardner et al., 2010), at a detection
threshold of ≥99%. The log likelihood for each of the positive
targets is estimated from the BLAST similarity scores of the
array feature and target sequences, together with the feature
sequence complexity and other covariates derived from BLAST
results.
Diversity of the fecal samples was measured by calculating
the number of families and species detected in each sample.
The mean number of families and species in the control and
transplant groups as well as the affected and unaffected groups
was compared prior to (−7 dpi) and after (0 dpi) FMT.
Microbiome composition was compared between these groups at
the level of phylum, family, and species.
16S rDNA Analysis of Fecal Samples
Pig fecal samples were collected in cryovials and stored at
−80◦C until shipment to the University of Nebraska–Lincoln
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for DNA extraction and bacterial community analysis. DNA
was extracted using the manufacturer’s protocol for Mag-Bind R©
Soil DNA 96 Kit (Omega Bio-tek, Inc.) with the following
modifications: precipitation of nucleic acids was done by using
sodium acetate, isopropanol, and ethyl alcohol. 0.1× volumes
of 10 mM sodium acetate was added to each sample tube,
which were vortexed and later incubated on ice for 5 min.
Subsequently, 1 ml of ice-cold isopropanol was added and
samples were incubated at −80◦C overnight to precipitate
the DNA. The following day, samples were centrifuged at
4◦C for 15 min at 16,000 × g. The supernatants of the
resulting samples were discarded and the nucleic acid pellet
was washed with 0.5 ml of ice-cold 70% ethyl alcohol. The
samples were centrifuged for 2 min at 13,000 × g, the residual
supernatant was discarded, and the nucleic acid pellet was air
dried for 3 min. The nucleic acid pellet was dissolved in a
0.45 ml of Tris (10 mM, pH 8) and incubated for 1 h at
4◦C. For further purification of dissolved nucleic acids, the
KingFisher (Thermo Fisher Scientific) robot was used with
reagents from the Mag-Bind R© Soil DNA 96 Kit. The resulting
DNA was used for the tag-sequencing of the V4 region of 16S
rDNA using the universal bacterial primers described previously
(Kozich et al., 2013). A 20 µl PCR reaction contained 1×
TerraTM PCR Direct Polymerase Mix, 0.5 µl Terra polymerase,
20 mM of each primer, and 20–50 µg of DNA. The cycling
conditions for PCR were the same as previously described
(Paz et al., 2016). The PCR product size was confirmed by
agarose gel electrophoresis. Normalization of the amplified
PCR products was performed with Just-a-PlateTM 96 PCR
Purification and Normalization kit (Charm Biotech, San Diego,
CA, United States) according to the manufacturer’s protocol.
Following normalization, 10 µl from each sample was pooled
and concentrated using Nucleospin R© Gel and PCR Cleanup
kit (MACHEREY-NAGEL Gmbh & Co. KG, Duren, Germany)
and was eluted using 20 µl of elution buffer. This pooled and
purified sample was analyzed in a Agilent 2100 bioanalyzer
(Agilent Scientific Instruments, Santa Clara, CA, United States)
using Agilent High Sensitivity DNA Kit (Agilent Technologies,
Inc., Waldbronn, Germany) to ensure the quality and quantity
of the targeted V4 region of 16S rDNA. The concentration
of the DNA library was determined using the DeNovix QFX
Fluorometer (DeNovix Inc., Wilmington, DE, United States)
and using DeNovix dsDNA Fluorescence Quantification Assay
(DeNovix Inc., Wilmington, DE, United States). The resulting
16S rDNA libraries were sequenced using the Illumina MiSeq
platform utilizing the 2 × 250 paired end sequencing strategy
using a MiSeq Reagent Kit V3 (Illumina Inc., San Diego, CA,
United States).
Data processing was performed on a custom pipeline
utilizing several publicly available software tools. The paired-
end reads were assembled into contigs after quality filtering
using MOTHUR v.1.38.1 (Schloss et al., 2009). Operational
taxonomic units (OTUs) were generated from the quality filtered
sequences using the UPARSE pipeline (USEARCH v7.0.1090)
(Edgar, 2013) at a threshold of 97% identity. Chimeric sequences
were removed using the ChimeraSlayer gold.fa as the reference
database using UCHIME (Edgar et al., 2011). OTUs were aligned
against the v128 (SILVA) database and mismatched sequences
were discarded. A phylogenetic tree was generated using
high-quality aligned sequences within MOTHUR v.1.38.1 using
the Clearcut algorithm (Sheneman et al., 2006). Taxonomies
to the identified OTUs were assigned using QIIME v.1.9.1
pipeline (Caporaso et al., 2010) with the Greengenes reference
database (gg_13_5_otus). OTUs representing Archaea and
Cyanobacteria were removed as Cyanobacterial reads may be
a result of contamination of plant chloroplast (Giovannoni
et al., 1988) and the archaea sequences may be biased as
the primers used are not designed to universally amplify
all archaea. Alpha diversity matrices (Chao1 and Observed
OTUs) were calculated using the QIIME v.1.9.1 pipeline. The
rarefaction of the OTU table was performed using QIIME
v.1.9.1 (Caporaso et al., 2010) with the lowest number of
reads. For the experiment, 27035 was used as the lowest depth.
The difference in bacterial communities (beta-diversity) among
transplanted and control pigs was determined using the QIIME
v.1.9.1 pipeline using distance matrices (weighted UniFrac,
unweighted UniFrac, and Bray Curtis) from the rarefied-OTU
table.
Statistical Analysis
For 16s rDNA sequencing, a three-way ANOVA (considering
the effect of treatment, day, and animal) was performed on
the Chao1 and observed OTUs to estimate bacterial richness
among the transplanted and control pigs with open source
statistical software R (R Core Team, 2013). The overall bacterial
community differences among treatments were determined by
applying the permutational multivariate analysis of variance
PERMANOVA on the weighted UniFrac distance matrix.
Principal coordinate analysis (PCoA) was used on all distance
matrices to generate plots which displayed global treatment
effects. The PERMANOVA analysis was performed using R (R
Core Team, 2015) (adonis function vegan package) (Oksanen
et al., 2015) in which treatment was considered as a fixed
effect and animal (pig) as a random effect with the pig as the
experimental unit. A core microbiome was determined for each
treatment group by only selecting the OTUs present in 80% of
the animals in each group (8/10). The core OTUs were used to
identify differential OTUs between treatments using the linear
discriminant analysis (LDA) effect size with LefSe (Segata et al.,
2011). LefSe analysis was performed using default settings and
differential OTUs from all pairwise comparisons to generate
heatmaps in R (R Core Team, 2015).
All remaining statistical analyses were performed using
GraphPad Prism 7.01 software (La Jolla, CA, United States).
Mean viremia, antibody levels, and weight measurements were
compared between groups using repeated measures analysis
with multiple unpaired t-tests. Survival curves were compared
using the Mantel–Cox test and daily morbidity rates were
compared using the Fisher’s exact test. Microscopic lung and
lymph node lesion scores were compared between groups using
the Mann–Whitney U-test. Gross photo scores and lung weight
to body weight ratios were compared using the unpaired t-test.
Microbiome diversity and number of species within family were
compared between groups using the Mann–Whitney U-test.
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Proportions of each group with individual species and families
detected were compared using Fisher’s exact test.
RESULTS
Characterization of Fecal Transplant
Material
Several methods, including aerobic culture, anaerobic culture,
microarray, and fecal float, were used to characterize the fecal
microbiota transplant material. Fecal floatation for parasites
confirmed feces were negative for parasites, including Ascaris
suum, through standard diagnostic testing at KSVDL. Aerobic
and anaerobic culture identified several culturable bacteria
known to inhabit the gastrointestinal tract, including non-
hemolytic Escherichia coli, Bacillus altitudinis, Streptococcus
alactolyticus, Enterococcus hirae, non-hemolytic Staphylococcus
sp., Bacteroides vulgatus, and Clostridium perfringens. Several
additional anaerobic bacteria were cultured but were unable
to be identified at the genus or species level; these bacteria
included Gram negative coccobacilli, Gram positive long rods,
and large Gram positive boxy rods. Salmonella enrichment
culture was negative. The pan-microbial array detected the
most diversity and absolute number of organisms, with 12
phyla, 33 microbial families, and 49 microbial species detected
(Table 1). Microbes were very diverse and from the phyla
Actinobacteria, Amoebozoa, Bacteroidetes, Basidiomycota,
Euryarchaeota, Firmicutes, Fusobacteria, Proteobacteria,
Spirochaetes, Synergistetes, and Tenericutes. Additionally, a
single virus was detected in the family Circoviridae. The majority
of species detected fell within the Proteobacteria phylum (16/49;
32.7%) with the second highest number of species falling with the
Firmicutes phylum (9/49; 18.4%) and the third highest number
of species falling within the Tenericutes phylum (6/49; 12.2%).
Using the above methods, known swine pathogens were not
detected.
TABLE 1 | Microorganisms detected in the fecal microbiota transplant material by the pan-microbial detection array.∗
Phylum‡ Family Genus species
Actinobacteria Bogoriellaceae Georgenia sp.
Nocardiaceae Rhodococcus rhodnii
Amoebozoa Entamoebidae Entamoeba nuttalli
Bacteroidetes Bacteroidaceae Bacteroides graminisolvens, Bacteroidetes bacterium
Cyclobacteriaceae Algoriphagus marincola
Prevotellaceae Prevotella sp.
Rikenellaceae Rikenella microfusus
Basidiomycota Ceratobasidiaceae Rhizoctonia solani
Euryarchaeota Methanobacteriaceae Methanobrevibacter oralis, Methanobrevibacter smithii
Firmicutes Carnobacteriaceae Alkalibacterium sp.
Clostridiaceae Candidatus Clostridium anorexicamassiliense, Clostridiaceae bacterium, Clostridium sp.
Clostridiales Clostridiales bacterium
Lachnospiraceae Lachnospiraceae bacterium
Lactobacillaceae Lactobacillus amylovorus
Peptostreptococcaceae Clostridium bifermentans, Clostridium mangenotii
Fusobacteria Fusobacteriaceae Psychrilyobacter atlanticus
Proteobacteria Anaplasmataceae Candidatus Xenolissoclinum pacificiensis
Bradyrhizobiaceae Bosea sp., Bradyrhizobium sp.
Campylobacteraceae Campylobacter sp., Sulfurospirillum arcachonense
Desulfovibrionaceae Desulfovibrio alkalitolerans
Helicobacteraceae Helicobacter pametensis
Legionellaceae Legionella lansingensis
Piscirickettsiaceae Thiomicrospira kuenenii, Thiomicrospira sp.
Pseudomonadaceae Pseudomonas sp., Rhizobacter sp.
Sphingomonadaceae Sphingomonas sp.
Vibrionaceae Candidatus Photodesmus katoptron
Xanthomonadaceae Ignatzschineria larvae, Xanthomonadaceae bacterium
Spirochaetes Spirochaetaceae Borrelia parkeri, Spirochaeta sp., Treponema pedis, Treponema sp.
Synergistetes Synergistaceae Aminiphilus circumscriptus
Tenericutes Acholeplasmataceae Acholeplasma equifetale, Acholeplasma granularum
Mycoplasmataceae Mycoplasma conjunctivae, Mycoplasma fermentans, Mycoplasma iowae
Spiroplasmataceae Spiroplasma apis
Virus Circoviridae Fur seal feces-associated circular DNA virus
∗Only those microbes identified at the phylum, family, and genus level are included. ‡Organized alphabetically by phylum; order listed when family unidentifiable.
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TABLE 2 | Effect of FMT on weight gain prior to co-infection.∗
Weight on arrival (−8 dpi) Weight after 7 days of FMT (0 dpi)
Control FMT Control FMT
4.73 5.41 5.09 5.32
5.05 5.59 5.23 5.77
5.82 5.82 5.86 6.05
6.77 5.91 7.50 6.23
7.27 6.14 7.91 6.64
7.36 8.23 8.23 8.27
7.64 8.23 8.41 8.45
8.27 8.32 8.59 8.45
8.73 8.45 9.59 8.68
8.91 8.64 9.64 8.95
Mean: 7.05 Mean: 7.07 Mean: 7.60 Mean: 7.28
SD: 1.46 SD: 1.39 SD: 1.67 SD: 1.40
p = 0.99 p = 0.85
∗Data are shown in kilograms. Statistics performed by unpaired t-tests using
repeated measures analysis.
FMT Had No Effect on Pigs Prior to
Co-infection
Upon arrival to Kansas State University, mean weight of the
control group was 7.05 ± 1.46 kg and mean weight of the
FMT group was 7.07 ± 1.39 kg (p = 0.99, unpaired t-test
using repeated measures; Table 2). No significant difference in
weight gain was noted during the transplantation or mock-
transplantation time period, suggesting no detrimental effect of
FMT on weight gain in unchallenged conditions; mean weights
for control pigs and FMT pigs on 0 dpi were 7.6 ± 1.7 and
7.3± 1.4 kg, respectively (p = 0.85, unpaired t-test using repeated
measures). FMT and control pigs appeared clinically within
normal limits.
FMT Reduced the Number of
PCVAD-Affected Pigs
Morbidity and mortality of the FMT and control groups are
shown in Figure 1. Morbidity rates of the control and FMT
groups were comparable in the first 22 days after co-infection
(Figure 1A). During this time, four control pigs and three
FMT pigs showed clinical signs, including dyspnea, open-
mouth breathing, coughing, tachypnea, mucoid rhinorrhea,
conjunctivitis, reduced body condition, lethargy/weakness, and
pyrexia. Starting on 23 dpi, the morbidity rates of the control and
FMT groups diverged, with five control pigs (5/8; 62.5%) and only
one FMT pig (1/8; 12.5%) exhibiting clinical signs sufficient to
require veterinary intervention, including depression, dyspnea,
tachypnea, coughing, open-mouth breathing, rough hair coat,
mucoid oculonasal discharge, pyrexia, emesis and diarrhea,
muscle wasting and loss of condition, ataxia, hypoxia, and
cyanosis. On days 25 and 26 after co-infection, morbidity rates
were significantly different (p = 0.04; Fisher’s exact test), with
75 and 12.5% of control and FMT pigs receiving treatment,
respectively. A trend toward significantly higher morbidity was
also seen on 27 dpi (p = 0.09; Fisher’s exact test) and 28 dpi
(p = 0.05; Fisher’s exact test). By 28 dpi, clinical disease had
completely resolved in the remaining eight FMT pigs while 50%
of control pigs (3/6) remained on treatment. Clinical disease
in affected FMT and control pigs (n = 9) was consistent with
PCVAD. Unaffected pigs (n = 11) had mild to a complete lack
of clinical signs. With regards to resulting mortality, initial death
rates were similar between the two groups, with 20% mortality
at 21 dpi. However, by the end of the study, the mortality in
the control group was 70% compared to 20% for the FMT
pigs (Figure 1B). Mortality between 19 and 30 dpi was due
to pigs that died or were euthanized due to severity of clinical
disease. Overall, the mortality rate of the control group (7/10,
70%) was significantly higher than that of the FMT group
(2/10, 20%; p = 0.0447, Mantel–Cox test). When taken together,
pigs which received the FMT treatment showed a reduction in
PCVAD.
The clinically affected pigs showed a decrease in weight gain
beginning at approximately 17 dpi (Figure 1C). Overall, no
significant differences were detected between the two groups
in regards to absolute weights during the biweekly or weekly
weight measurements throughout the study (p > 0.05, repeated
measures analysis with multiple t-tests). The one exception was
the final weights on 42 dpi, where the three remaining control
pigs had a mean weight significantly higher than that of the
eight remaining FMT pigs (p = 0.04, repeated measures analysis).
During peak clinical disease between 17 and 30 dpi, seven control
pigs lost body weight whereas only two FMT pigs lost body weight
(p = 0.07, Fisher’s exact test). Control pigs were 9.3 times more
likely to lose weight during this period (95% CI: 1–56.5). Overall,
FMT reduced the number of pigs which lost weight associated
with clinical PCVAD.
Representative gross and microscopic lesions seen in pigs
with PCVAD are shown in Figure 2. Images of minimally
affected pigs are included for comparison. Examples of gross
lesions included interstitial pneumonia with consolidation
and hemorrhage, splenic infarcts, mucohemorrhagic rhinitis,
lymphadenopathy with congestion and edema, pericardial
effusion, mucohemorrhagic exudate in trachea, serous atrophy of
fat, enteritis and intestinal ulceration, infarction of extremities,
and tonsillar congestion. On gross examination of lung
tissue, pneumonia was overall more severe in the control
group, with 70% of the control pigs having severe interstitial
pneumonia with marked edema, coupled with enlarged lymph
nodes, characteristic of PCVAD. In addition, a few of the
affected pigs in the control group had bronchopneumonia
and fibrinous pleuritis. Interestingly, these pigs also had
severe suppurative rhinitis. Rhinitis, bronchopneumonia, and
pleuritis are suggestive of a secondary bacterial infection,
likely due to immunosuppression associated with both PRRSV
and PCV-2 infections. In contrast, only 30% of the FMT
group had severe interstitial pneumonia and enlargement
of the lymph nodes on gross examination, characteristic of
PCVAD.
Gross lung tissue images were captured during necropsy and
subsequently scored for severity of lesions (Figures 2E,F, 3A).
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FIGURE 1 | Morbidity and mortality of pigs with and without fecal microbiota transplantation prior to co-infection with PRRSV and PCV-2d. (A) Percent morbidity
over time; data are shown as the percent of pigs in each group with veterinary treatment prescribed due to moderate to severe clinical disease. Asterisks demarcate
statistically significant differences (∗p < 0.05 and ‡p < 0.1; Fisher’s exact test). (B) Survival curve shows a significantly higher survival rate in pigs administered the
FMT. (C) Weight gain is shown as the mean ± standard deviation of control and FMT groups considered unaffected and affected by PCVAD, as identified by
mortality and clinical disease. The surviving pigs in each group are shown at the bottom of the figure over time.
Control pigs had a range of 30.5–99.0% of lung affected, with a
mean of 82.4 ± 20.3%. FMT pigs had a range of 10.0–99.0% of
lung affected, with a mean of 53.6± 40.6%. These differences had
a trend toward significance (p = 0.06, unpaired t-test). A lung
weight-to-body weight ratio was calculated for each pig and
is depicted in Figure 3B. Control pigs had significantly higher
ratios when compared to FMT pigs (p = 0.04, unpaired t-test),
indicative of increased cellular infiltrate and edema characteristic
of interstitial pneumonia.
Lesions were also assessed through histopathology. Micro-
scopic lesions in the lungs included lymphoplasmacytic
and histiocytic interstitial pneumonia, suppurative bronch-
opneumonia, and interlobular septal edema and hemorrhage.
Lymphoid depletion with histiocytic replacement was seen in
the tracheobronchial lymph nodes. Lymphoid depletion was
scored in all 20 pigs, with 7/10 control and 3/10 FMT pigs
having severe lymphoid depletion (Figures 2A, 3C). Although
lymphoid depletion scores were generally higher in control pigs,
this difference was not statistically significant (p = 0.155, Mann–
Whitney U-test). Severe lymphoid depletion was associated
with large amounts of PCV-2 antigen (Figure 2A). Degree of
interstitial pneumonia was also scored in all 20 pigs, with 6/10
control and 2/10 FMT pigs having severe diffuse interstitial
pneumonia with >75% lung lobe involvement (Figures 2C, 3D).
Control pigs again tended to have higher overall severity
of microscopic lung lesions; however, this difference was
not statistically significant (p = 0.164, Mann–Whitney
U-test).
Taken together, the control pigs trended toward having more
severe gross and microscopic lesions associated with PCVAD
when compared to pigs that received the transplant material,
indicating that FMT provided partial protection from both
respiratory and lymphoid disease. This difference was seen due
to an increased number of PCVAD-affected pigs in the control
group.
FMT Reduced PRRSV and PCV-2 Virus
Replication and Increased Antibody
Production
Porcine reproductive and respiratory syndrome virus and PCV-
2 viremia curves are shown for both individual pigs as well as
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FIGURE 2 | Representative gross and microscopic lesions associated with porcine circovirus associated disease (PCVAD). Images shown are from representative
PCVAD-affected pigs with severe clinical disease between 19 and 30 dpi or minimally affected pigs for the purpose of comparison. (A) Immunohistochemical
staining of a tracheobronchial lymph node showing severe lymphoid depletion associated with large amounts of PCV-2 antigen. (B) Immunohistochemical staining of
a tracheobronchial lymph node showing lymphoid follicles with minimal lymphoid depletion and no PCV-2 antigen staining. (C) H&E-stained lung showing severe
diffuse interstitial pneumonia affecting greater than 75% of lung. (D) H&E-stained lung showing mild and multifocal interstitial pneumonia affecting less than 50% of
lung. (E) Dorsal and ventral gross lung showing severe consolidation, hemorrhage, and pneumonia affecting approximately 95% of lung. (F) Dorsal and ventral gross
lung showing minimal consolidation, hemorrhage, and pneumonia affecting approximately 12% of lung.
group means (Figure 4). PRRSV viremia followed the typical
time course, peaking at 7 dpi prior to a gradual decline over the
next 5 weeks. Interestingly, most of the PCVAD-affected pigs had
PRRS viremia rebound, a phenomenon initially described in 2010
(Reiner et al., 2010) and later by our group (Boddicker et al.,
2012). For example, one control pig had peak PRRSV replication
at 7 dpi (5.8 log10 copy number/25 µl reaction volume), a gradual
decline of PRRSV replication until a low at 21 dpi (2.9 log10 copy
number/25 µl reaction volume), and a second peak of PRRSV
replication at 30 dpi (5.9 log10 copy number/25 µl reaction
volume). When comparing mean PRRSV replication between
groups, the only significant difference was seen at 28 dpi where
the control group had significantly higher viremia; a mean of
3.9 and 3.0 log10 copy number/25 µl reaction volume was seen
for control and FMT groups, respectively (p = 0.02, repeated
measures analysis).
Porcine circovirus type 2 viremia also followed the typical
time course, peaking later in the co-infection period between 14
and 21 dpi, followed by a plateau through the conclusion of the
study. Interestingly, all nine pigs that died had significantly higher
levels of PCV-2 replication when compared to pigs that survived
the course of the study (Figures 4D,E,H). Specifically, surviving
pigs maintained <7 log10 copy number/20 µl reaction volume
in the serum at all measurements whereas pigs that died had
>7 log10 copy number/20 µl reaction volume detected during the
study. When comparing the two groups’ mean PCV-2 replication,
significant differences were seen on 7 and 21 dpi, where the FMT
group had a more rapid increase in PCV-2 replication on 7 dpi
and a more rapid decline in PCV-2 replication on 21 dpi (p = 0.02
and 0.03, respectively; repeated measures analysis). Overall,
PCVAD-affected pigs had high levels of PCV-2 and PRRSV in
serum at the time of death or euthanasia, confirming the role
of viral load in the course of clinical disease (Figures 4G,H). In
general, virus replication during peak clinical disease was reduced
in the FMT group, demonstrating a protective effect of FMT on
viral load.
Antibodies were measured against PRRSV N protein, PCV-
2 whole capsid protein (CP 43-233), and PCV-2 decoy epitope
(CP 160-233). PRRSV antibodies were detected similarly in both
groups initially on 7 dpi and peaking between 11 and 14 dpi
(Figure 5A). PRRSV antibodies were detected at a greater level in
FMT pigs on 21, 28, and 42 dpi (p = 0.06, p = 0.02, and p = 0.05,
respectively; repeated measures analysis). When comparing PCV-
2 antibody levels (Figures 5B,C), a similar trend was noted with
FMT pigs having higher antibody levels. FMT pigs had higher
CP 43-233 antibodies at 21 and 28 dpi whereas the FMT pigs
maintained higher CP 160-233 antibodies from 21 dpi until the
conclusion of the study. Taken together, FMT promoted the
production of higher and more sustained levels of antibodies
directed at both PRRSV and PCV-2.
FMT Shifted Microbiome Composition
Fecal microbiomes of the transplanted and control groups were
analyzed both before and after FMT or mock-transplantation
by a pan-microbial array (LLMDA) and 16S rDNA sequencing.
First, microbiome composition and diversity were measured
by the LLMDA. Diversity was calculated as the mean number
of species and families in each group; after transplantation,
the mean number of species was 62.3 ± 2.7 and 59.9 ± 4.2
for the control and FMT groups, respectively. With regards to
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FIGURE 3 | Degree of lung and lymphoid lesions in pigs after co-infection with PRRSV and PCV-2d. Data are shown as individual scores at the time of death with
horizontal lines representing the mean ± 1 standard deviation for each group. Pigs shown in red are those that died or were humanely euthanized due to severity of
disease. (A) Gross lung affected by pneumonia. Mean percent of lung affected was lower in FMT when compared to Controls (p = 0.06, unpaired t-test). (B) Lung
weight-to-body weight ratio at the time of necropsy showing the control pigs had significantly higher ratios (p = 0.037, unpaired t-test). (C) Lymphoid depletion mean
scores were higher in the control group (2.5 ± 0.3) when compared to the FMT group (1.9 ± 0.3), but differences were not statistically significant. (D) Microscopic
lung lesion mean scores were higher in the control group (3.3 ± 0.3) when compared to the FMT group (2.7 ± 0.3), but differences were not statistically significant.
family diversity, the mean number of families on 0 dpi in the
control group was 35.3 ± 2.7 while the transplant group had
33.8 ± 2.6. Interestingly, no significant differences in species
or family diversity were detected in the FMT group compared
to the controls after transplantation using the pan-microbial
array. Microbiome diversity, as measured by the microarray,
was also similar in the two groups upon arrival (data not
shown).
Microbiome composition was also assessed by the LLMDA
through the presence of individual phyla, families, and species
in the two groups. After 7 days of transplantation, there were 64
total families and 166 total species detected in both the control
and transplanted groups. Several differences were detected
between the transplant and control groups after transplantation
that were not detected upon arrival (Figure 6A). Specifically, the
family Synergistaceae was detected at a decreased prevalence rate
in the transplanted group after FMT compared to the controls
(20 and 70%, respectively; p = 0.07; Fisher’s exact test) and a
bacterium in the Intrasporangiaceae family was detected in a
higher proportion of the transplant pigs when compared to the
control pigs (100 and 50%, respectively; p = 0.03; Fisher’s exact
test). Even though members of the Intrasporangiaceae family
have been discovered in environmental samples and sequenced
(Weissbrodt et al., 2014; Zhao et al., 2017), there is a lack of
research exploring the effects of these organisms on the vertebrate
gut microbiome.
Finally, species diversity within each family was assessed
for differences associated with transplantation (Figure 6B).
Most families had similar species diversity between the
control and transplanted groups. However, within the families
Spirochaetaceae and Vibrionaceae, there was greater species
diversity in the control group compared to the transplanted
group. The mean number of species within the family
Spirochaetaceae was 2.6 species in the control group, while
in the transplant group it was 2.0 species (p = 0.01; Mann–
Whitney U-test). The mean number of species within the
family Vibrionaceae was 1.6 species in controls, while in
the transplant group it was 0.8 species (p = 0.02; Mann–
Whitney U-test). Overall, the LLMDA failed to detect a global
increase in microbiome diversity after 7 days of transplantation;
however, several shifts in microbiome composition were detected,
primarily based on a reduction in bacteria generally considered
pathogenic.
A secondary analysis was performed to assess microbiome
diversity between PCVAD-affected and unaffected pigs using
the LLMDA. Affected and unaffected pigs had similar mean
Frontiers in Microbiology | www.frontiersin.org 11 July 2018 | Volume 9 | Article 1631
fmicb-09-01631 July 19, 2018 Time: 16:25 # 12
Niederwerder et al. FMT Reduces PCVAD in Pigs
FIGURE 4 | Time course of PRRSV and PCV-2d viremia. Data are shown as the log10 copy number/PCR reaction volume for individual pigs in both the control and
FMT groups (A,B for PRRSV; D,E for PCV-2d). Red boxes indicate pigs that died or were humanely euthanized during the course of the co-infection trial due to
severity of disease. (C,F) Data are shown as mean log10 copy number/PCR reaction volume ± 1 standard deviation for each group. Asterisks demarcate statistically
significant differences for PRRSV and PCV-2d. (G,H) Data are shown as PRRSV and PCV-2 viremia in PCVAD-affected (circles) and PCVAD-unaffected (squares)
pigs within the control and FMT groups, as measured by mortality and clinical disease.
numbers of families and species when compared on days −7
and 0 post-infection. However, there was a significant increase
detected in the number of families in the unaffected pigs between
−7 and 0 dpi, with the mean number of families detected
increasing from 28.9 to 33.7 during the transplantation period
(p = 0.03; Mann–Whitney U-test). Although an increase in family
diversity was also seen in the affected pigs between−7 and 0 dpi,
this difference was not statistically significant (p = 0.20; Mann–
Whitney U-test). Species diversity also increased in both affected
and unaffected pigs during the transplantation period, albeit at
a similar rate (p = 0.07 and p = 0.09 for unaffected and affected
pigs, respectively; Mann–Whitney U-test). Taking the results
together from the LLMDA, there is some evidence suggesting
that pigs unaffected by PCVAD after challenge had a greater
increase in microbiome diversity during the transplantation
period.
Fecal bacterial communities of the control and transplanted
groups were also analyzed using 16S rDNA sequencing both prior
to and immediately following transplantation (Supplementary
Figures 1, 2). A total of 2,446,796 quality-filtered 16S rDNA
sequences of the V4 region were generated with an average
read depth of 61,169 reads per sample. To determine if
sampling depth was adequate for gut microbiota analysis, Good’s
coverages were calculated, which displayed that 99.4–99.8% of
the bacterial community in the gut was represented in the
dataset.
The Chao1 alpha-diversity metric for richness was similar in
the transplant and control animals at 7 days post transplantation
(p ≥ 0.82; Supplementary Figure 1A). The phylum level
distribution of the major taxa in both control and transplanted
pigs included Bacteroidetes, Firmicutes, and Proteobacteria.
Interestingly, the phylum Actinobacteria was almost half in the
transplanted group compared to the control group (1.7 vs. 3.3%,
respectively; Supplementary Figure 1B). The family level analysis
of the transplanted and control animals revealed Prevotellaceae,
Paraprevotellaceae, Bacteroidales S24-7, Lactobacillaceae,
Christensenellaceae, Lachnospiraceae, Ruminococcaceae, and
Veillonellaceae to be the predominant families (Supplementary
Figure 1C). Phyla composition was not significantly different
across the transplant and control animals. Bacterial communities
did not cluster by treatment group, suggesting no global shifts in
the bacterial populations as a result of the FMT. However, there
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FIGURE 5 | Detection of antibody in transplanted and control pigs. Data are shown as the mean sample:positive ratio ± 1 standard deviation for PRRSV (A), PCV-2
large epitope (B), and PCV-2 decoy epitope (C). Differences between the two group are shown as ∗p < 0.03 and ‡p < 0.06 (repeated measures analysis using
multiple t-tests).
was a significant day effect displayed during transplantation
(p < 0.001).
To reduce animal–animal variation, a core measurable
microbiome (CMM) was defined for the control and transplanted
groups. For the transplant group, the CMM was composed of
306 OTUs (23.5% of total OTUs), which represented 81.1% of
the rarefied quality-filtered reads. For the control group, the
CMM was composed of 316 OTUs (25.3% of total OTUs), which
represented 83.2% of the rarefied quality-filtered reads.
To further investigate potential bacterial community
differences across the transplanted and control groups,
differentially abundant OTUs across the CMM were identified
using the LefSe algorithm (Segata et al., 2011). A total of 30
significant, differentially abundant OTUs with LDA scores
≥2 were identified across comparisons of the two groups
(Supplementary Figure 2). The differential OTUs associated
with the transplant group belong to the bacterial families
Veillonellaceae, Lachnospiraceae, and Ruminococcaceae.
Additionally, the 16S rDNA bacterial community composition
was analyzed based on the prevalence of disease in the PCVAD-
affected (n = 9) and unaffected (n = 11) pigs. A two-way ANOVA
was performed on the Chao1 and observed OTUs to determine
the effect of subsequent disease phenotype on pre-challenge
bacterial diversity. Both measures of bacterial diversity were
lower in the affected group on 0 dpi (Supplementary Figure 3);
however, these differences were not statistically significant
(p ≥ 0.14 and p ≥ 0.24, respectively). We also performed beta-
diversity analysis to determine the effect of the disease phenotype
on global microbial community diversity using PERMANOVA
analysis. This analysis demonstrated no differences in community
composition based on disease phenotype (p≥ 0.46), but detected
a significant effect of day (p < 0.001) on the bacterial community
composition.
DISCUSSION
Although FMT has been accepted for centuries as a treatment for
various gastrointestinal diseases, it has only been very recently
that FMT has been recognized as an alternative therapeutic for
diseases outside of the gastrointestinal tract, such as respiratory
or neurologic diseases (Bakker and Nieuwdorp, 2017; Staley et al.,
2017). Moreover, using FMT as a prophylactic tool prior to the
development of disease has been even less explored. The current
study describes FMT efficacy when used as a prophylactic tool
to prevent PCVAD in pigs infected with two important swine
pathogens. Additionally, the study was conducted in a manner
in line with current swine industry standards, where pigs are
typically handled at 3 weeks of age after weaning and without
broad-spectrum antimicrobial therapy.
To identify beneficial characteristics of the FMT material,
two diagnostic tests were used for characterization: (1) a
pan-microbial array and (2) bacterial culture. Comparing
these results reveals several discrepancies between the two
different detection methods. Interestingly, several bacteria
cultured through standard methods, such as Escherichia coli
and Streptococcus sp., are not detected on the pan-microbial
array. Culture methods may promote growth of certain well-
characterized bacterial species, even if the genome is present at
a rate lower than that detectable by the microarray. Previous
studies have reported similar results. For example, Sung et al.
(2018) reported bacterial species detected in bronchoalveolar
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FIGURE 6 | Fecal microbiome composition as detected by the pan-microbial array in FMT and control pigs after 7 days of transplantation. (A) Microbiome family
composition is shown as the percent of FMT pigs (n = 10) and control pigs (n = 10) with each family detected on the pan-microbial array. Families with a total
prevalence of <40% between the FMT and control groups are not shown. There was a significantly higher prevalence of a species within the family
Intrasporangiaceae in the FMT group. A trend toward a higher percentage of control pigs having species within the family Synergistaceae was also detected
(‡p = 0.07; Fisher’s exact test). (B) Data are shown as the mean number of species detected ± 1 standard deviation in each family identified in FMT and control
pigs. Within the families Spirochaetaceae and Vibrionaceae, there was greater species diversity in the control group compared to the transplanted group. † Indicates
families found in the transplant material.
lavage fluid by both conventional culture techniques as well as
next-generation sequencing (NGS). Similar to the current study,
they detected some species only by culture and other species only
by sequencing, with increased diversity detected in the genome-
based technique. Interestingly, the genera Staphylococcus and
Escherichia were only detected by culture and not by NGS
(Sung et al., 2018), a result similar to our findings on the
transplant material. However, with these two species being
common environmental microbes, contamination of the bacterial
culture must also be considered. With advantages and limitations
to each diagnostic test, using culture and DNA-based techniques
in combination can serve to provide a more comprehensive
characterization of complex microbial communities.
Biphasic clinical disease after co-infection with PRRSV and
PCV-2 has been described previously (Niederwerder et al., 2015,
2016). Clinical disease associated with PRRS is typically seen
in the first 21 dpi, during peak PRRSV replication. In contrast,
clinical disease associated with PCVAD is typically seen after
21 dpi and is associated with the peak and plateau in PCV-
2 replication. Although respiratory signs are common in both
phases, clinical disease associated with PCVAD is typically more
severe and associated with significant weight loss and muscle
wasting. Compared to previous studies where PCV-2b was used,
the current study used PCV-2d, which has been recently reported
as the most common circulating PCV-2 genotype in US swine
(Xiao et al., 2016). This use of PCV-2d appeared to increase
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morbidity and mortality rates of co-infected pigs. The principal
effect of FMT in the co-infection model was to decrease the
number of PCVAD-affected pigs, as demonstrated by a significant
reduction in morbidity and mortality. Specifically, a 70%
reduction in mortality of transplanted pigs was demonstrated.
Additionally, parenteral antimicrobial treatments prescribed for
clinical disease were reduced by 60% in the FMT group. With
increasing pressure to eliminate antimicrobial usage in food
animal production, a 60% decrease in prescribed antimicrobials
is a significant effect, important to both human and animal
health. Interestingly, FMT did not appear to significantly impact
clinical disease in the first half of the co-infection period, typically
associated with PRRS. Nevertheless, further research is warranted
to understand if FMT improves response to PRRS in a PRRSV-
only infection model.
The mechanisms by which FMT is effective are poorly
understood but thought to be associated with increasing
microbial diversity and restoring normal microbial communities
which provide both local and systemic benefits to the host
(Khoruts and Sadowsky, 2016). How FMT protected nursery pigs
from developing PCVAD in this study is unknown, but may
be due to several possible mechanisms. First, FMT increased
the relative abundance of several bacterial families associated
with metabolism, including Veillonellaceae, Lachnospiraceae, and
Ruminococcaceae. The members of the Lachnospiraceae family
are fermentative, anaerobic, chemoorganotrophic, and have the
ability to hydrolyze many different substrates, such as xylanase,
α- and β-glucosidase, and α- and β-galactosidase (Stackebrandt,
2014). Bacteria in the Ruminococcaceae family are common
gut microbes of animals and humans, which help the host
break down complex carbohydrates (Ben David et al., 2015).
Both Lachnospiraceae and Ruminococcaceae have previously
been associated with fatness traits in pigs (He et al., 2016)
and our previous work detected a positive association between
Ruminococcaceae species and growth after co-infection (Ober
et al., 2017). In the current study, the comparison of absolute
weights over time in the two groups was significantly impacted by
the high mortality rate in the control pigs; as such, the increase in
weight in the remaining control pigs at the conclusion of the trial
was likely the result of decreased competition for feed. Evaluating
the weight gain of individual pigs, it is clear that the weight gain
of the control pigs was impacted to a greater extent than the FMT
pigs throughout the trial.
As a second possible mechanism, FMT may modulate
the systemic immune response, increasing the function of
immune cells or stimulating cytokine production. In the current
study, evidence for an enhanced immune response to both
PRRSV and PCV-2 was demonstrated by a reduction in
pulmonary pathology as well as a more robust and prolonged
antibody response to both viruses detected in the serum of
transplanted pigs. It is also possible that FMT may enhance
gastrointestinal health and provide competitive exclusion of
pathogens. Supporting this possible mechanism in the current
study was the documented reduction of two bacterial families
thought to be primary pathogens, including Spirocheataceae and
Vibrionaceae (Tsinganou and Gebbers, 2010; Karami et al., 2014;
Le Roux et al., 2015), in transplanted pigs.
Perhaps surprising in the current study was the lack of
significant global increases of microbiome diversity in pigs
receiving the transplant. In humans, where FMT is most
commonly used to treat recurrent C. difficile infections, patients
have almost always been treated with several standard doses
of antibiotics, making an increase in microbiome diversity
more likely with FMT therapy. Even in these human patients,
however, Staley et al. (2016) reported that successful resolution
of C. difficile infections through FMT treatment did not
require complete microbiota engraftment (Staley et al., 2016).
Similarly to the current study, it does not appear that
complete microbiota engraftment occurred in transplanted
pigs; nonetheless, significant beneficial effects occurred due to
transplantation.
Compared to humans receiving FMT, an important concept
to discuss for the current study is that pigs were not treated
with antimicrobials and thus had normal microbiomes for
their age at the time of transplantation. Pigs were weaned at
3 weeks and allowed normal contact with sows and a commercial
environment after birth. The rationale behind this experimental
design was to model commercial conditions, where antimicrobial
stewardship practices have made it increasingly important to
avoid the use of antimicrobials for prophylactic use, and to
evaluate FMT as a preventative tool that may be applied to swine
production in the field, including its use as a replacement for
antimicrobials. However, this could be considered a limitation of
the study, due to our inability to control the microbiota present
at the time of transplantation, such as would be the case had
microbiota-depleted or germ-free pigs been utilized.
A second consideration should be the lack of gender and
donor diversity in the current study; the FMT material was
collected from two older sows and transplanted into weaned
barrows. Although the FMT donors were selected based on
several specific characteristics and requirements, it should be
noted that donation from other sows or boars may have resulted
in a different outcome. Gender has been previously described
as a factor affecting the success, failure, or effect of FMT. For
example, Meighani et al. (2016) reported that female sex was a
significant predictor of FMT failure when treating humans with
recurrent C. difficile infection (Meighani et al., 2016). In contrast,
Siegerstetter et al. (2018) demonstrated that female chickens
trended toward having higher feed intake (p = 0.087) and weight
gain (p = 0.081) after FMT; this same beneficial effect of FMT was
not seen in male chickens (Siegerstetter et al., 2018). Regarding
the current study, it is unknown how FMT collected from boars
or administration to weaned gilts would have impacted the study
outcome. Additional research is warranted to understand the
effects of gender, both in collection and administration, on FMT
efficacy in swine.
Decades of research into control of respiratory disease
associated with PRRS have failed to produce a broadly protective
vaccine or programs capable of long-term virus elimination
from farms. Due to the significant economic and animal welfare
impacts that respiratory disease continues to have on the
swine industry, it is necessary to consider alternative strategies,
such as FMT, for the control of respiratory disease in swine
production. Very recently, microbiome therapeutics have been
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developed for the prevention and/or treatment of diseases in
the respiratory tract of children. For example, in May 2017,
a microbiome therapeutic utilizing a mixture of four gut
bacteria, including Faecalibacterium, Lachnospira, Veillonella,
and Rothia (FLVR), was announced for preventing childhood
asthma and potentially other childhood allergic diseases (Arrieta
et al., 2015; Anonymous, 2017). Interestingly, three of those
bacterial families were differentially expressed in FMT pigs
post-transplantation. Utilizing beneficial gut microbes for the
prevention and treatment of respiratory disease is an emerging
and exciting area of study. As respiratory infections are a major
cause of morbidity and mortality in swine and other livestock,
FMT or other microbiome therapeutics provide a promising
approach for control of these complex, often polymicrobial, and
economically devastating diseases.
CONCLUSION
This study provides evidence of the significant relationship
between the gut microbiome and outcome following systemic
viral infections in swine. Most importantly, novel insight
is provided into our ability to modulate the microbiome
through FMT to improve the clinical outcome of pigs to
common pathogens. Future research is necessary to understand
the mechanism behind this relationship and how large-scale
microbiome modulation could be adapted to increase the health
of PRRS-positive herds in the field.
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